A skin patch containing a mixture of myelin peptides significantly reduced clinical and imaging evidence of disease activity in patients with relapsing-remitting multiples sclerosis in a controlled trial conducted in Poland.

http://www.newsdaily.com/health/7e27a9e52df34db47c63d5327d2859e5/myelin-peptide-patch-shows-promise-in-multiple-sclerosis 

Results  All patients completed the study. Compared with placebo, treatment with a myelin peptide skin patch (1 mg) showed a 66.5% reduction in the cumulative number of Gd+ lesions (P =  .02) during the 12 months of the study. The annual relapse rate in patients treated with a mixture of myelin peptides (1 mg) was significantly lower compared with the placebo group (0.43 vs 1.4; P = .007). Treatment with a myelin peptide skin patch was well tolerated and no serious adverse events were reported.

http://archneur.jamanetwork.com/article.aspx?articleid=1704351